FIELD: virology.
SUBSTANCE: described is a method of differentiating the vaccine strain "VGNKI" of the adenoviral infection agent from other strains and field isolates by analyzing the melting point maxima of PCR products using a tandem fluorescent dye SuperNova v605, involving the use of selected oligonucleotide primers.
EFFECT: wider range of technical means for differentiation of the vaccine strain "VGNKI" of the adenoviral infection agent from other strains and field isolates of the adenoviral infection agent.
2 cl, 4 dwg, 6 tbl, 3 ex
Authors
Dates
2024-09-02—Published
2023-09-12—Filed